Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A study of the effectiveness of intranasal ketamine in the treatment of moderate to severe pain in the emergency department


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12611001102965

Organisation Name: Southern Health

Overal Status: Completed

Start Date: 16/02/2012

Brief Summary: This study aims ot assess the effectiveness of ketamine as an pain reliever when administered into the nasal passages in doses that do not produce sedation or anaesthesia in a group of adult emergency department patients coming to hospital with moderate to severe pain.
We hypothesise that ketamine will reduce pain effectively without significant sedation at the proposed dose.
A positive result may allow ketamine to be considered as an alternative pain reliever for acute pain in the emergency department that could be adminsitered through the nose and reduce the need for insertion of intravenous catheters in some patients suffering from moderate to severe pain.

Countries:
  • Australia


Total execution time in seconds: 0.17489218711853